Carl D Regillo

Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema.

Jason Hsu, Gui-Shuang Ying, Allen C Ho, 2015, American journal of ophthalmology.

Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients.

C. Regillo, David M. Brown, David M Brown, 2007, American journal of ophthalmology.

Pegaptanib for choroidal neovascularization in treatment-naïve exudative age-related macular degeneration.

Allen C Ho, Justis P Ehlers, A. Ho, 2007, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration.

Allen C Ho, A. Ho, C. Regillo, 2014, Ophthalmology.